1Incentive policy evaluation on orphan drugs in the United States during 1983—2019YANG Jing-shu, YANG Dian-zheng, YANG Yue1921-19272Analysis on the necessity of international multi-regional clinical trials of imported prophylactic vaccines in ChinaLI Ze-lin, YANG Jian-hong, DONG Jiang-ping1928-19333Pharmacology and clinical evaluation of the RNA polymerase Ⅱ inhibitor lurbinectedinLAN Hua, ZHANG Ya-tong, WANG Yang1934-19394Risankizumab: a new biological agent for the treatment of psoriasisLI Xiang-jun, WU Ai-ping, ZHANG Li1940-19435Considerations on the application of antimicrobial preservatives in drugsTANG Zhen, ZHAO Xiao-xia, GUAN Hong-feng, ZHANG Yong-wen1944-19486Discussion on the related problems of supplementary testing methods and items of traditional Chinese medicineCHEN Xia, ZHANG Yong-wen, ZHOU Gang1949-19557General considerations for viral safety control of recombinant therapeutic biotechnological products during the CTA phaseSAI Wen-bo, GUO Sheng-nan, WEI Kai-kun1956-19608The key issues in clinical research of investigational Chinese medicine in mammary hyperplasiaCHENG Jin-lian, ZHANG Dong-xiao, LIU Xue-mei1961-19669Verification of applicability of the method for detecting CHO host cell protein residuesZHANG Feng, QIN Jian, GUO Sha, WANG Lan1967-197410Preparation and preliminary characterization of anti-GPC3/NKG2D bispecific fusion proteinLIU Yun-hui, GE Chen, XU Qin-zhi, QIAN Ni-liang, YANG Hui, WAN Ling-fei, YAN Xin-long, GAO Xin1975-198111Research progress for controlled release mechanism of smart drug carrierFAN Yue-yue, HAO Wen-yan, ZHANG Sha-sha, YANG Yang, GAO Chun-sheng1982-198912Progress on the study of drug accelerated stability modelDUAN Li, LI Na, HAN Lu, DU Ying, XU Hui, TAN De-jiang1990-199713Determination and risk analysis for potential N-nitrosamines in azithromycin injectionWU Yang, XU Qi, QIAN Yan, HUANG Yi-wen1998-200214Rivaroxaban-induced bleeding: analysis of literature in China and abroadSUN Xue, GUO Cai-hui, SONG Hao-jing, DONG Zhan-jun2003-200815Mini health technology assessment of four antiangiogenic agents for advanced NSCLCREN Bing-nan, XUE Chao-jun, LI Xiao, ZHAO Yue, DONG Zhan-jun2009-2016